-
Je něco špatně v tomto záznamu ?
Utility and Actual Use of European and Spanish Guidelines on the Management of Endometrial Cancer Among Gynecologic Oncologists in Spain
I. Zapardiel, C. Blancafort, D. Cibula, I. Jaunarena, M. Gorostidi, A. Gil-Moreno, J. De Santiago, . ,
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články, práce podpořená grantem
- MeSH
- dodržování směrnic statistika a číselné údaje MeSH
- dospělí MeSH
- gynekologie metody normy statistika a číselné údaje MeSH
- lékařská onkologie metody normy statistika a číselné údaje MeSH
- lékařská praxe - způsoby provádění statistika a číselné údaje MeSH
- lidé středního věku MeSH
- lidé MeSH
- nádory endometria diagnóza terapie MeSH
- průřezové studie MeSH
- průzkumy a dotazníky MeSH
- směrnice pro lékařskou praxi jako téma MeSH
- Check Tag
- dospělí MeSH
- lidé středního věku MeSH
- lidé MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- Geografické názvy
- Španělsko MeSH
OBJECTIVE: The aim of the study was to analyze the current management of endometrial cancer across Spain and to evaluate the use and applicability of the national and international guidelines. MATERIALS AND METHODS: An electronic 30-question survey was distributed among all Spanish Society of Obstetrics and Gynecology-registered specialists dedicated to gynecologic oncology in Spain by e-mail. Data were collected anonymously and analyzed using SPSS program. RESULTS: One hundred forty-five (17.8%) surveys were collected. Significant differences were observed between tertiary hospitals and secondary or private hospitals in terms of appropriate (according to European Society of Gynaecologic Oncology guidelines) nodal staging in low-risk cases (96 [95%] vs 27 [61.4%], respectively; P < 0.001), appropriate nodal staging in intermediate-risk cases (96 [95%] vs 39 [88.6%], respectively; P = 0.004), appropriate treatment in advanced-stage cases (63 [67.7%] vs 13 [40.6%], respectively; P < 0.001), and surgical treatment of relapses (87 [93.5%] vs 18 [56.3%], respectively; P = 0.004) but nonsignificant in the rate of complete paraaortic lymphadenectomy performance (82 [81.2%] vs 28 [63.6%], respectively; P = 0.056). Similar results have been observed when comparing centers with less than 20 cases per year to centers with more than 40 cases annually, with significant differences in the management of low-risk and intermediate-risk endometrial cancers. CONCLUSIONS: This cross-sectional study demonstrates a broad heterogeneity of care giving between the clinical national and international guidelines and the actual practice in Spain. Although most of the responders refer to base their endometrial cancer management on Spanish and European Society of Gynaecologic Oncology guidelines (64.1%), many discrepancies have been observed, mainly in the management of intermediate-risk cases and follow-up. It may be caused by the lack of consensus on certain points, lack of facilities in lower case load centers, and also due to disagreement or unawareness on the current knowledge.
§Gynecologic Oncology Unit Hospital Universitario Donostia San Sebastian
¶Department of Gynecology MD Anderson Cancer Center Madrid Spain
*Gynecologic Oncology Unit La Paz University Hospital IdiPAZ Madrid
†Gynecology Department Dexeus University Institute Barcelona Spain
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc18010499
- 003
- CZ-PrNML
- 005
- 20180404142054.0
- 007
- ta
- 008
- 180404s2017 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1097/IGC.0000000000001017 $2 doi
- 035 __
- $a (PubMed)28604452
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Zapardiel, Ignacio $u *Gynecologic Oncology Unit, La Paz University Hospital, IdiPAZ, Madrid; †Gynecology Department, Dexeus University Institute, Barcelona, Spain; ‡Gynecologic Oncology Center, Department of Gynecology and Obstetrics, First Faculty of Medicine and General University Hospital, Charles University in Prague, Prague, Czech Republic; §Gynecologic Oncology Unit, Hospital Universitario Donostia, San Sebastian; ∥Unit of Gynecologic Oncology, Department of Obstetrics and Gynecology, Hospital Materno-infantil Vall d'Hebron, Universitat Autonoma de Barcelona, Barcelona; and ¶Department of Gynecology, MD Anderson Cancer Center, Madrid, Spain.
- 245 10
- $a Utility and Actual Use of European and Spanish Guidelines on the Management of Endometrial Cancer Among Gynecologic Oncologists in Spain / $c I. Zapardiel, C. Blancafort, D. Cibula, I. Jaunarena, M. Gorostidi, A. Gil-Moreno, J. De Santiago, . ,
- 520 9_
- $a OBJECTIVE: The aim of the study was to analyze the current management of endometrial cancer across Spain and to evaluate the use and applicability of the national and international guidelines. MATERIALS AND METHODS: An electronic 30-question survey was distributed among all Spanish Society of Obstetrics and Gynecology-registered specialists dedicated to gynecologic oncology in Spain by e-mail. Data were collected anonymously and analyzed using SPSS program. RESULTS: One hundred forty-five (17.8%) surveys were collected. Significant differences were observed between tertiary hospitals and secondary or private hospitals in terms of appropriate (according to European Society of Gynaecologic Oncology guidelines) nodal staging in low-risk cases (96 [95%] vs 27 [61.4%], respectively; P < 0.001), appropriate nodal staging in intermediate-risk cases (96 [95%] vs 39 [88.6%], respectively; P = 0.004), appropriate treatment in advanced-stage cases (63 [67.7%] vs 13 [40.6%], respectively; P < 0.001), and surgical treatment of relapses (87 [93.5%] vs 18 [56.3%], respectively; P = 0.004) but nonsignificant in the rate of complete paraaortic lymphadenectomy performance (82 [81.2%] vs 28 [63.6%], respectively; P = 0.056). Similar results have been observed when comparing centers with less than 20 cases per year to centers with more than 40 cases annually, with significant differences in the management of low-risk and intermediate-risk endometrial cancers. CONCLUSIONS: This cross-sectional study demonstrates a broad heterogeneity of care giving between the clinical national and international guidelines and the actual practice in Spain. Although most of the responders refer to base their endometrial cancer management on Spanish and European Society of Gynaecologic Oncology guidelines (64.1%), many discrepancies have been observed, mainly in the management of intermediate-risk cases and follow-up. It may be caused by the lack of consensus on certain points, lack of facilities in lower case load centers, and also due to disagreement or unawareness on the current knowledge.
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a průřezové studie $7 D003430
- 650 _2
- $a nádory endometria $x diagnóza $x terapie $7 D016889
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a dodržování směrnic $x statistika a číselné údaje $7 D019983
- 650 _2
- $a gynekologie $x metody $x normy $x statistika a číselné údaje $7 D006176
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a lékařská onkologie $x metody $x normy $x statistika a číselné údaje $7 D008495
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a směrnice pro lékařskou praxi jako téma $7 D017410
- 650 _2
- $a lékařská praxe - způsoby provádění $x statistika a číselné údaje $7 D010818
- 650 _2
- $a Španělsko $7 D013030
- 650 _2
- $a průzkumy a dotazníky $7 D011795
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Blancafort, Claudia
- 700 1_
- $a Cibula, David
- 700 1_
- $a Jaunarena, Ibon
- 700 1_
- $a Gorostidi, Mikel
- 700 1_
- $a Gil-Moreno, Antonio
- 700 1_
- $a De Santiago, Javier
- 700 1_
- $a ,
- 773 0_
- $w MED00009896 $t International journal of gynecological cancer official journal of the International Gynecological Cancer Society $x 1525-1438 $g Roč. 27, č. 6 (2017), s. 1293-1297
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/28604452 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20180404 $b ABA008
- 991 __
- $a 20180404142134 $b ABA008
- 999 __
- $a ok $b bmc $g 1287984 $s 1007311
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2017 $b 27 $c 6 $d 1293-1297 $i 1525-1438 $m International journal of gynecological cancer $n Int J Gynecol Cancer $x MED00009896
- LZP __
- $a Pubmed-20180404